New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

Bastos-Oreiro, Mariana; Abrisqueta, Pau; Gutiérrez, Antonio; Jiménez-Ubieto, Ana; Poza, María; Fernanez-Caldas, Paula; LLacer, María-José; González-de-Villambrosía, Sonia; Córdoba, Raúl; López, Alberto; Ceballos, Elena; Navarro, Belén; Muntañola, Ana; Donato, Eva; Díez-Baeza, Eva; Escoda, Lourdes; Luzardo, Hugo; Peñarrubia, María-José; García-Belmonte, Daniel; Pardal, Emilia; Lozada, Claudia; Martín-García-Sancho, Alejandro

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.06. Área de Salud VI Vega Media
→
02.06.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	Bastos-Oreiro, Mariana
dc.contributor.author	Abrisqueta, Pau
dc.contributor.author	Gutiérrez, Antonio
dc.contributor.author	Jiménez-Ubieto, Ana
dc.contributor.author	Poza, María
dc.contributor.author	Fernanez-Caldas, Paula
dc.contributor.author	LLacer, María-José
dc.contributor.author	González-de-Villambrosía, Sonia
dc.contributor.author	Córdoba, Raúl
dc.contributor.author	López, Alberto
dc.contributor.author	Ceballos, Elena
dc.contributor.author	Navarro, Belén
dc.contributor.author	Muntañola, Ana
dc.contributor.author	Donato, Eva
dc.contributor.author	Díez-Baeza, Eva
dc.contributor.author	Escoda, Lourdes
dc.contributor.author	Luzardo, Hugo
dc.contributor.author	Peñarrubia, María-José
dc.contributor.author	García-Belmonte, Daniel
dc.contributor.author	Pardal, Emilia
dc.contributor.author	Lozada, Claudia
dc.contributor.author	Martín-García-Sancho, Alejandro
dc.date.accessioned	2025-11-18T09:33:30Z
dc.date.available	2025-11-18T09:33:30Z
dc.date.issued	2024
dc.identifier.citation	Bastos-Oreiro M, Abrisqueta P, Gutierrez A, Jiménez Ubieto A, Poza M, Fernanez-Caldas P, et al. New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group. HemaSphere. abril de 2024;8(4):e70.
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/20862
dc.description.abstract	To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and integrase strand transfer inhibitors (INSTI) in Spain during the period 2019-2021
dc.language.iso	eng
dc.publisher	John Wiley And Sons Inc
dc.subject.mesh	Humans
dc.subject.mesh	HIV Infections/drug therapy/epidemiology
dc.subject.mesh	Spain/epidemiology
dc.subject.mesh	Phylogeny
dc.subject.mesh	Anti-HIV Agents/pharmacology/therapeutic use
dc.subject.mesh	Anti-Retroviral Agents/pharmacology/therapeutic use
dc.subject.mesh	Integrases/genetics/therapeutic use
dc.subject.mesh	Mutation
dc.subject.mesh	Drug Resistance, Viral/genet
dc.title	New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	38650598
dc.relation.publisherversion	https://onlinelibrary.wiley.com/doi/10.1002/hem3.70
dc.identifier.doi	10.1002/hem3.70
dc.journal.title	Hemasphere
dc.identifier.essn	2572-9241